Highest-materiality recent filing
Scotts Miracle-Gro Q2 net sales +5% to $1.46B; adj. EPS $4.53 beats $4.00 YoY
GAAP diluted EPS from continuing ops $4.46 vs $3.78; adjusted EPS $4.53 vs $4.00, up 13%.
ScottsMiracle-Gro sells Hawthorne to Vireo for 213M shares plus warrants
Consideration: 213M subordinate voting Vireo Shares and warrants for 80M additional shares.
Scotts Miracle-Gro reclassifies Hawthorne as discontinued ops for sale; revises prior financials
Hawthorne business classified as held for sale in Q1 2026; results reclassified as discontinued operations.
Scotts Miracle-Gro reports Q1 net loss of $0.83/sh, announces Hawthorne sale to Vireo, $500M buyback
U.S. Consumer net sales $328.5M; GAAP gross margin 25.0% (+90 bps); net leverage improved to 4.03x.
SMG FY2025 adj EPS $3.74, gross margin up 490 bps; guides FY2026 adj EPS $4.15-$4.35
FY2025 adj EPS $3.74 vs $2.29 prior year; GAAP EPS $2.47 vs ($0.61) prior year.
Scotts Miracle-Gro Q3 GAAP EPS $2.54, adj. EPS $2.59; reaffirms FY guidance
GAAP net income $149.1M ($2.54/diluted share) vs. $132.1M ($2.28) a year ago; non-GAAP adj. $151.5M ($2.59).
Scotts Miracle-Gro Q2 GAAP EPS $3.72; adjusted EBITDA $402.8M, reaffirms guidance
Q2 GAAP EPS $3.72 vs $2.74 prior year; adjusted EPS $3.98 vs $3.69.
Scotts Miracle-Gro Q1 adj. EBITDA improves $30M; reaffirms FY guidance; lowers interest expense view
Q1 net loss $69.5M ($1.21/sh) vs $80.5M ($1.42/sh) YoY; adj. loss $0.89/sh improved $0.56.
Full-year revenue $3.6B flat; U.S. Consumer up 6% to $3.0B; Hawthorne down 37% to $294.7M.
Scotts Miracle-Gro Q3 adjusted EPS $2.31 doubles YoY; U.S. Consumer sales up 11%
GAAP EPS $2.28 vs $0.77; Non-GAAP adjusted EPS $2.31 vs $1.17, more than doubling YoY.
ScottsMiracle-Gro Q2 GAAP EPS $2.74, adj. EPS $3.69; reaffirms FY2024 targets
Q2 net sales flat at $1.53B; U.S. Consumer record $1.38B (+2% YoY); Hawthorne down 28% to $66.4M.
On January 31, 2025, the Board, upon the recommendation of the Nominating and Governance Committee of the Board (“Nominating Committee”), appointed Nick Miaritis as a Class II member of the Board to fill a vacancy arising from Mr. Kelly’s departure.
On January 27, 2025, Tom Kelly, a member of the Board of Directors (the “Board”), notified The Scotts Miracle-Gro Company (the “Company”) of his resignation from the Board with his term ending January 31, 2025.
On November 4, 2024, the Board, upon the recommendation of the Nominating and Governance Committee of the Board (“Nominating Committee”), appointed Roberto Candelino as a Class I member of the Board to fill a vacancy.
Max materiality 0.85 · Median 0.68 · Most common event earnings